Unraveling the Complexity of Fatigue in Multiple Sclerosis: John DeLuca, PhD
The senior vice president for Research and Training at Kessler Foundation talked about the issue of fatigue in patients with multiple sclerosis and the significant, multifaceted challenges patients face. [WATCH TIME: 5 minutes]
WATCH TIME: 5 minutes
“Fatigue is the most significant symptom that patients with MS talk about that affects their lives, and [fatigue] affects them in a variety of different ways. Do we understand what fatigue is by what the patients are telling us? We have fatigue instruments that we use, but part of the issue is that these fatigue instruments don't measure fatigue alone.”
A prevalent symptom experienced among patients with
DeLuca sat down in an interview with NeurologyLive® at the meeting to give an overview of the presentation and how clinicians are currently treating fatigue in their clinical practice. He talked about the existing instruments for measuring fatigue and if they accurately capture the experiences and impact of the symptoms reported in patients with MS. He also explained how primary fatigue, caused by MS in the brain, can be effectively measured and understood. In addition, DeLuca spoke about the treatment approaches that might show promise for managing fatigue in MS.
REFERENCES
1. Dobryakova E, Genova HM, DeLuca J, Wylie GR. The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders. Front Neurol. 2015;6:52. Published 2015 Mar 12. doi:10.3389/fneur.2015.00052
2. DeLuca, J. What is Fatigue and Can We Measure It?. Part 1: Understanding Fatigue and its Clinical Management. Presented at: 2023 CMSC Annual Meeting; May 31 to June 3; Aurora, CO.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- Perispinal Etanercept Shows No Efficacy in Treating Chronic Stroke
September 16th 2025